Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '1 alpha,25-(OH)(2)D-3' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hummert, TW; Schwartz, Z; Sylvia, VL; Dean, DD; Boyan, BD
      Stathmin levels in growth plate chondrocytes are modulated by vitamin D-3 metabolites and transforming growth factor-beta 1 and are associated with proliferation

      ENDOCRINE
    2. Sylvia, VL; Del Toro, F; Hardin, RR; Dean, DD; Boyan, BD; Schwartz, Z
      Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D-3 effects on growth zone chondrocytes

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    3. Rao, DS; Balkundi, D; Uskokovic, MR; Tserng, KY; Clark, JW; Horst, RL; Reddy, GS
      Double bond in the side chain of 1 alpha,25-dihydroxy-22-ene-vitamin D-3 is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    4. Kitanaka, S; Takeyama, K; Murayama, A; Kato, S
      The molecular basis of vitamin D-dependent rickets type I

      ENDOCRINE JOURNAL
    5. Rao, LG; Liu, LJF; Rawlins, MR; McBroom, RJ; Murray, TM; Reddy, GS; Uskokovic, MR; Rao, DS; Sutherland, MK
      The biological activities of 1 alpha,25-dihydroxyvitamin D-3 and its synthetic analog 1 alpha,25-dihydroxy-16-ene-vitamin D-3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    6. Mikami, K; Ohba, S; Ohmura, H; Kubodera, N; Nakagawa, K; Okano, T
      Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D-3 A-ring analog with significant transactivation activity

      CHIRALITY
    7. Siu-Caldera, ML; Rao, DS; Astecker, N; Weiskopf, A; Vouros, P; Konno, K; Fujishima, T; Takayama, H; Peleg, S; Reddy, GS
      Tissue specific metabolism of 1 alpha,25-dihydroxy-20-epi-vitamin D-3 intonew metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8)

      JOURNAL OF CELLULAR BIOCHEMISTRY
    8. Kamao, M; Tatematsu, S; Reddy, GS; Hatakeyama, S; Sugiura, M; Ohashi, N; Kubodera, N; Okano, T
      Isolation, identification and biological activity of 24R,25-dihydroxy-3-epivitamin D-3: A novel metabolite of 24R,25-dihydroxyvitamin D-3 produced inrat osteosarcoma cells (UMR 106)

      JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
    9. Nishii, Y; Okano, T
      History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2 beta-(3-hydroxypropoxy)calcitriol (ED-71)

      STEROIDS
    10. Norman, AW; Henry, HL; Bishop, JE; Song, XD; Bula, C; Okamura, WH
      Different shapes of the steroid hormone 1 alpha,25(OH)(2)-vitamin D-3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses

      STEROIDS
    11. Ishizuka, S; Miura, D; Ozono, K; Saito, M; Eguchi, H; Chokki, M; Norman, AW
      (23S)- and (23R)-25-dehydro-1 alpha-hydroxyvitamin D-3-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1 alpha,25-dihydroxyvitamin D-3

      STEROIDS
    12. Zhao, XY; Feldman, D
      The role of vitamin D in prostate cancer

      STEROIDS
    13. Nakagawa, K; Sowa, Y; Kurobe, M; Ozono, K; Siu-Caldera, ML; Reddy, GS; Uskokovic, MR; Okano, T
      Differential activities of 1 alpha,25-dihydroxy-16-ene-vitamin D-3 analogsand their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis

      STEROIDS
    14. Xie, ZJ; Bikle, DD
      The role of phospholipase C-gamma 1 in 1 alpha,25-dihydroxyvitamin D-3 regulated keratinocyte differentiation

      STEROIDS
    15. Kadiyala, S; Nagaba, S; Takeuchi, K; Yukihiro, S; Qiu, WP; Eyes, ST; Uskokovic, MR; Posner, GH; Reddy, GS; Guggino, SE
      Metabolites and analogs of 1 alpha,25-dihydroxyvitamin D-3: evaluation of actions in bone

      STEROIDS
    16. Farach-Carson, MC
      Bioactive analogs that simulate subsets of biological activities of 1 alpha,25(OH)(2)D-3 in osteoblasts

      STEROIDS
    17. Boyan, BD; Sylvia, VL; Dean, DD; Schwartz, Z
      24,25-(OH)(2)D-3 regulates cartilage and bone via autocrine and endocrine mechanisms

      STEROIDS
    18. Schuster, I; Egger, H; Bikle, D; Herzig, G; Reddy, GS; Stuetz, A; Stuetz, P; Vorisek, G
      Selective inhibition of vitamin D hydroxylases in human keratinocytes

      STEROIDS
    19. Rao, DS; Campbell, MJ; Koeffler, HP; Ishizuka, S; Uskokovic, MR; Spagnuolo, P; Reddy, GS
      Metabolism of 1 alpha,25-dihydroxyvitamin D-3 in human promyelocytic leukemia (HL-60) cells: In vitro biological activities of the natural metabolites of 1 alpha,25-dihydroxyvitamin D-3 produced in HL-60 cells

      STEROIDS
    20. Reddy, GS; Muralidharan, KR; Okamura, WH; Tserng, KY; McLane, JA
      Metabolism of 1 alpha,25-dihydroxyvitamin D-3 and its C-3 epimer 1 alpha,25-dihydroxy-3-epi-vitamin D-3 in neonatal human keratinocytes

      STEROIDS
    21. Schuster, I; Egger, H; Astecker, N; Herzig, G; Schussler, M; Vorisek, G
      Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes

      STEROIDS
    22. Uskokovic, MR; Norman, AW; Manchand, PS; Studzinski, GP; Campbell, MJ; Koeffler, HP; Takeuchi, A; Siu-Caldera, ML; Rao, DS; Reddy, GS
      Highly active analogs of 1 alpha,25-dihydroxyvitamin D-3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways

      STEROIDS
    23. Ibi, M; Sawada, H; Nakanishi, M; Kume, T; Katsuki, H; Kaneko, S; Shimohama, S; Akaike, A
      Protective effects of 1 alpha,25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

      NEUROPHARMACOLOGY
    24. Schwartz, Z; Lohmann, CH; Vocke, AK; Sylvia, VL; Cochran, DL; Dean, DD; Boyan, BD
      Osteoblast response to titanium surface roughness and 1 alpha,25-(OH)(2)D-3 is mediated through the mitogen-activated protein kinase (MAPK) pathway

      JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    25. Aronsson, BO; Hjorvarsson, B; Frauchiger, L; Taborelli, M; Vallotton, PH; Descouts, P
      Hydrogen desorption from sand-blasted and acid-etched titanium surfaces after glow-discharge treatment

      JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
    26. Okano, T; Nakagawa, K; Kubodera, N; Ozono, K; Isaka, A; Osawa, A; Terada, M; Mikami, K
      Catalytic asymmetric syntheses and biological activities of singly dehydroxylated 19-nor-1 alpha,25-dihydroxyvitamin D-3 A-ring analogs in cancer cell differentiation and apoptosis

      CHEMISTRY & BIOLOGY
    27. Campbell, MJ; Gombart, AF; Kwok, SH; Park, S; Koeffler, HP
      The anti-proliferative effects of 1 alpha,25(OH)(2)D-3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression

      ONCOGENE
    28. Kroncke, KD; Carlberg, C
      Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide

      FASEB JOURNAL
    29. Buitrago, C; Vazquez, G; De Boland, AR; Boland, RL
      Activation of Src kinase in skeletal muscle cells by 1,25-(OH)(2)-vitamin D-3 correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction

      JOURNAL OF CELLULAR BIOCHEMISTRY
    30. Harant, H; Spinner, D; Reddy, GS; Lindley, IJD
      Natural metabolites of 1 alpha,25-dihydroxyvitamin D-3 retain biologic activity mediated through the vitamin D receptor

      JOURNAL OF CELLULAR BIOCHEMISTRY
    31. Astecker, N; Reddy, GS; Herzig, G; Vorisek, G; Schuster, I
      1 alpha 25-dihydroxy-3-epi-vitamin D-3 a physiological metabolite of 1 alpha,25-dihydroxyvitamin D-3: Its production and metabolism in primary human keratinocytes

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    32. Suzuki, T; Sano, Y; Sotozono, C; Kinoshita, S
      Regulatory effects of 1 alpha,25-dihydroxyvitamin D-3 on cytokine production by human corneal epithelial cells

      CURRENT EYE RESEARCH
    33. Skliar, M; Curino, A; Milanesi, E; Benassati, S; Boland, R
      Nicotiana glauca: another plant species containing vitamin D-3 metabolites

      PLANT SCIENCE
    34. Lee, NE; Williard, PG; Brown, AJ; Campbell, MJ; Koeffler, HP; Peleg, S; Rao, DS; Reddy, GS
      Synthesis and biological activities of the two C(23) epimers of 1 alpha,23,25-trihydroxy-24-oxo-19-nor-vitamin D-3: novel analogs of 1 alpha,23(S),25-trihydroxy-24-oxo-vitamin D-3, a natural metabolite of 1 alpha,25-dihydroxyvitamin D-3

      STEROIDS
    35. Johansen, C; Iversen, L; Ryborg, A; Kragballe, K
      1 alpha,25-dihydroxyvitamin D-3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    36. Nakagawa, K; Kurobe, M; Konno, K; Fujishima, T; Takayama, H; Okano, T
      Structure-specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60) cells by a ring diastereomers of 2-methyl-1 alpha,25-dihydroxyvitamin D-3 and its 20-epimer

      BIOCHEMICAL PHARMACOLOGY
    37. Reddy, GS; Rao, DS; Siu-Caldera, ML; Astecker, N; Weiskopf, A; Vouros, P; Sasso, GJ; Manchand, PS; Uskokovic, MR
      1 alpha,25-dihydroxy-16-ene-23-yne-vitamin D-3 and 1 alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D-3: Analogs of 1 alpha,25-dihydroxyvitamin D-3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    38. Ishizuka, S; Miura, D; Eguchi, H; Ozono, K; Chokki, M; Kamimura, T; Norman, AW
      Antagonistic action of novel 1 alpha,25-dihydroxyvitamin D-3-26,23-lactoneanalogs on 25-hydroxyvitamin-D-3-24-hydroxylase gene expression induced by1 alpha,25-dihydroxyvitamin D-3 in human promyelocytic leukemia (HL-60) cells

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    39. Siu-Caldera, ML; Sekimoto, H; Weiskopf, A; Vouros, P; Muralidharan, KR; Okamura, WH; Bishop, J; Norman, AW; Uskokovic, MR; Schuster, I; Reddy, GS
      Production of 1 alpha,25-dihydroxy-3-epi-vitamin D-3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): Existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed

      BONE
    40. Gabriels, S; Van Haver, D; Vandewalle, M; De Clercq, P; Viterbo, D
      On the unexpected stereochemical outcome of the magnesium in methanol - Conjugate reduction of an exocyclic alpha,beta-unsaturated ester

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    41. Trisi, P; Rao, W; Rebaudi, A
      A histometric comparison of smooth and rough titanium implants in human low-density jawbone

      INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
    42. Norman, AW; Adams, D; Collins, ED; Okamura, WH; Fletterick, RJ
      Three-dimensional model of the ligand binding domain of the nuclear receptor for 1 alpha,25-dihydroxy-vitamin D-3

      JOURNAL OF CELLULAR BIOCHEMISTRY
    43. Brown, AJ; Ritter, C; Slatopolsky, E; Muralidharan, KR; Okamura, WH; Reddy, GS
      1 alpha,25-dihydroxy-3-epi-vitamin D-3, a natural metabolite of 1 alpha,25-dihydroxyvitamin D-3, is a potent suppressor of parathyroid hormone secretion

      JOURNAL OF CELLULAR BIOCHEMISTRY
    44. Huang, WH; Zheng, MH
      Steroid hormones and bone

      HISTOLOGY AND HISTOPATHOLOGY
    45. Norman, AW; Song, XD; Zanello, L; Bula, C; Okamura, WH
      Rapid and genomic biological responses are mediated by different shapes ofthe agonist steroid hormone, 1 alpha,25(OH)(2)vitamin D-3

      STEROIDS
    46. Weinstein, EA; Rao, DS; Siu-Caldera, ML; Tserng, KY; Uskokovic, MR; Ishizuka, S; Reddy, GS
      Isolation and identification of 1 alpha-hydroxy-24-oxovitamin D-3 and 1 alpha,23-dihydroxy-24-oxovitamin D-3 - Metabolites of 1 alpha,24 (R)-dihydroxyvitamin D-3 produced in rat kidney

      BIOCHEMICAL PHARMACOLOGY
    47. MATSUMOTO T; SOWA Y; OHTANIFUJITA N; TAMAKI T; TAKENAKA T; KURIBAYASHI K; SAKAI T
      P53-INDEPENDENT INDUCTION OF WAF1 CIP1 IS CORRELATED WITH OSTEOBLASTIC DIFFERENTIATION BY VITAMIN-D-3/

      Cancer letters
    48. BATZER R; LIU Y; COCHRAN DL; SZMUCKLERMONCLER S; DEAN DD; BOYAN BD; SCHWARTZ Z
      PROSTAGLANDINS MEDIATE THE EFFECTS OF TITANIUM SURFACE-ROUGHNESS ON MG63 OSTEOBLAST-LIKE CELLS AND ALTER CELL RESPONSIVENESS TO 1-ALPHA,25-(OH)(2)D-3

      Journal of biomedical materials research
    49. BOYAN BD; BATZER R; KIESWETTER K; LIU Y; COCHRAN DL; SZMUCKLERMONCLER S; DEAN DD; SCHWARTZ Z
      TITANIUM SURFACE-ROUGHNESS ALTERS RESPONSIVENESS OF MG63 OSTEOBLAST-LIKE CELLS TO 1-ALPHA,25-(OH)(2)D-3

      Journal of biomedical materials research
    50. SATO M; IGA H; YOSHIOKA N; FUKUI K; KAWAMATA H; YOSHIDA H; HIROTA S; KITAMURA Y
      EMERGENCE OF OSTEOBLAST-LIKE CELLS IN A NEOPLASTIC HUMAN SALIVARY CANCER CELL-LINE AFTER TREATMENT WITH 22-OXA-1-ALPHA,25-DIHYDROXYVITAMIN D-3

      Cancer letters
    51. TOMOYASU S; FUKUCHI K; WATANABE K; UENO H; HAMANO Y; HISATAKE J; HINO K; GOMI K; TSURUOKA N
      REVERSIBILITY OF MONOCYTIC DIFFERENTIATION OF HL-60 CELLS BY 1-ALPHA,25 DIHYDROXYVITAMIN D-3

      Leukemia research
    52. FURUICHI T; KAWATA S; ASOH Y; KUMAKI K; OHYAMA Y
      DIFFERENTIAL TIME-COURSE OF INDUCTION OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3-24-HYDROXYLASE MESSENGER-RNA EXPRESSION IN RATS BY 1-ALPHA,25-DIHYDROXYVITAMIN D-3 AND ITS ANALOGS

      Life sciences
    53. ZHOU LX; NORMAN AW
      CHARACTERIZATION OF THE 2ND-MESSENGER INVOLVED IN 1-ALPHA,25-DIHYDROXYVITAMIN D-3 STIMULATED INTESTINAL CALCIUM-ABSORPTION (TRANSCALTACHIA)

      Endocrine
    54. HATAKEYAMA S; OHARANEMOTO Y; KYAKUMOTO S; SATOH M
      RETINOIC ACID ENHANCES EXPRESSION OF BONE MORPHOGENETIC PROTEIN-2 IN HUMAN ADENOCARCINOMA CELL-LINE (HSG-S8)

      Biochemistry and molecular biology international
    55. MOTTERSHEAD DG; POLLY P; LYONS RJ; SUTHERLAND RL; WATTS CKW
      HIGH-ACTIVITY, SOLUBLE, BACTERIALLY EXPRESSED HUMAN VITAMIN-D-RECEPTOR AND ITS LIGAND-BINDING DOMAIN

      Journal of cellular biochemistry
    56. WIBERG K; LJUNGHALL S; BINDERUP L; LJUNGGREN O
      STUDIES ON 2 NEW VITAMIN-D ANALOGS, EB-1089 AND KH-1060 - EFFECTS ON BONE-RESORPTION AND OSTEOCLAST RECRUITMENT IN-VITRO

      Bone
    57. KISSMEYER AM; MATHIASEN IS; LATINI S; BINDERUP L
      PHARMACOKINETIC STUDIES OF VITAMIN-D ANALOGS - RELATIONSHIP TO VITAMIN-D-BINDING PROTEIN (DBP)

      Endocrine
    58. NORMAN AW
      THE VITAMIN-D ENDOCRINE SYSTEM - MANIPULATION OF STRUCTURE-FUNCTION-RELATIONSHIPS TO PROVIDE OPPORTUNITIES FOR DEVELOPMENT OF NEW CANCER CHEMOPREVENTIVE AND IMMUNOSUPPRESSIVE AGENTS

      Journal of cellular biochemistry
    59. KAKEGAWA H; TAGAMI K; OHBA Y; SUMITANI K; KAWATA T; KATUNUMA N
      SECRETION AND PROCESSING MECHANISMS OF PROCATHEPSIN-L IN BONE-RESORPTION

      FEBS letters
    60. TSURUKAMI H; NAKAMURA T; SUZUKI K; SATO K; HIGUCHI Y; NISHII Y
      A NOVEL SYNTHETIC VITAMIN-D ANALOG, BETA-(3-HYDROXYPROPOXY)1-ALPHA,25-DIHYDROXYVITAMIN D-3 (ED-71), INCREASES BONE MASS BY STIMULATING THE BONE-FORMATION IN NORMAL AND OVARIECTOMIZED RATS

      Calcified tissue international


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 07:39:19